CA-074 methyl ester
For Laboratory Research Only. Not for Clinical or Personal Use.
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


CA-074 methyl ester
Description:
CA-074 methyl ester is a specific inhibitor of Cathepsin B, which has potent bioactivities such as neuroprotective, anti-cancer, and anti-inflamatory effects.Product Name Alternative:
CA-074MeUNSPSC:
12352005Hazard Statement:
H302, H315, H319, H335Target:
CathepsinType:
Reference compoundRelated Pathways:
Metabolic Enzyme/ProteaseApplications:
Cancer-Kinase/proteaseField of Research:
Neurological Disease; CancerAssay Protocol:
https://www.medchemexpress.com/CA-074-methyl-ester.htmlPurity:
99.34Solubility:
DMSO : 100 mg/mL (ultrasonic) |H2O : < 0.1 mg/mL (ultrasonic; warming; heat to 60°C)Smiles:
O=C([C@@H]1[C@@H](C(NCCC)=O)O1)N[C@]([C@@H](C)CC)([H])C(N(CCC2)[C@@H]2C(OC)=O)=OMolecular Formula:
C19H31N3O6Molecular Weight:
397.47Precautions:
H302, H315, H319, H335References & Citations:
[1]Xu Y, et al. Protective mechanisms of CA074-me (other than cathepsin-B inhibition) against programmed necrosis induced by global cerebral ischemia/reperfusion injury in rats. Brain Res Bull. 2016 Jan;120:97-105|[2]Patel N, et al. CA-074Me compound inhibits osteoclastogenesis via suppression of the NFATc1 and c-FOS signaling pathways. J Orthop Res. 2015 Oct;33 (10) :1474-86|[3]Zhang L, et al. Treatment with CA-074Me, a Cathepsin B inhibitor, reduces lung interstitial inflammation and fibrosis in a rat model of polymyositis. Lab Invest. 2015 Jan;95 (1) :65-77Shipping Conditions:
Blue IceStorage Conditions:
-20°C, 3 years (Powder)Scientific Category:
Reference compound1Clinical Information:
No Development ReportedIsoform:
Cathepsin BCAS Number:
[147859-80-1]
